Evergreen Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$554K Buy
6,686
+1,625
+32% +$135K 0.02% 517
2025
Q1
$410K Hold
5,061
0.01% 586
2024
Q4
$456K Hold
5,061
0.01% 544
2024
Q3
$500K Hold
5,061
0.02% 496
2024
Q2
$469K Hold
5,061
0.02% 485
2024
Q1
$480K Buy
5,061
+61
+1% +$5.79K 0.02% 460
2023
Q4
$446K Hold
5,000
0.02% 450
2023
Q3
$365K Hold
5,000
0.02% 489
2023
Q2
$416K Hold
5,000
0.02% 439
2023
Q1
$381K Sell
5,000
-50
-1% -$3.81K 0.02% 439
2022
Q4
$419K Hold
5,050
0.02% 404
2022
Q3
$401K Hold
5,050
0.02% 386
2022
Q2
$375K Sell
5,050
-11
-0.2% -$817 0.02% 378
2022
Q1
$455K Hold
5,061
0.02% 394
2021
Q4
$567K Hold
5,061
0.02% 356
2021
Q3
$636K Hold
5,061
0.03% 327
2021
Q2
$685K Hold
5,061
0.03% 301
2021
Q1
$687K Hold
5,061
0.04% 290
2020
Q4
$712K Sell
5,061
-5,900
-54% -$830K 0.04% 253
2020
Q3
$1.22M Hold
10,961
0.08% 186
2020
Q2
$1.23M Buy
10,961
+561
+5% +$62.8K 0.09% 175
2020
Q1
$805K Buy
10,400
+600
+6% +$46.4K 0.08% 183
2019
Q4
$932K Hold
9,800
0.08% 178
2019
Q3
$747K Hold
9,800
0.07% 180
2019
Q2
$860K Buy
9,800
+4,800
+96% +$421K 0.08% 173
2019
Q1
$453K Hold
5,000
0.05% 225
2018
Q4
$359K Sell
5,000
-1,800
-26% -$129K 0.04% 240
2018
Q3
$652K Hold
6,800
0.06% 201
2018
Q2
$647K Buy
+6,800
New +$647K 0.06% 195